Cite
Stereotactic Cavity Irradiation or Whole-Brain Radiotherapy Following Brain Metastases Resection—Outcome, Prognostic Factors, and Recurrence Patterns
MLA
Rami A. El Shafie, et al. “Stereotactic Cavity Irradiation or Whole-Brain Radiotherapy Following Brain Metastases Resection—Outcome, Prognostic Factors, and Recurrence Patterns.” Frontiers in Oncology, vol. 10, May 2020. EBSCOhost, https://doi.org/10.3389/fonc.2020.00693.
APA
Rami A. El Shafie, Thorsten Dresel, Dorothea Weber, Daniela Schmitt, Kristin Lang, Laila König, Simon Höne, Tobias Forster, Bastian von Nettelbladt, Tanja Eichkorn, Sebastian Adeberg, Jürgen Debus, Stefan Rieken, & Denise Bernhardt. (2020). Stereotactic Cavity Irradiation or Whole-Brain Radiotherapy Following Brain Metastases Resection—Outcome, Prognostic Factors, and Recurrence Patterns. Frontiers in Oncology, 10. https://doi.org/10.3389/fonc.2020.00693
Chicago
Rami A. El Shafie, Thorsten Dresel, Dorothea Weber, Daniela Schmitt, Kristin Lang, Laila König, Simon Höne, et al. 2020. “Stereotactic Cavity Irradiation or Whole-Brain Radiotherapy Following Brain Metastases Resection—Outcome, Prognostic Factors, and Recurrence Patterns.” Frontiers in Oncology 10 (May). doi:10.3389/fonc.2020.00693.